Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New and emerging therapies for acute and chronic graftversushost disease
LaQuisa C. Hill, Amin M. Alousi, Partow Kebriaei, et al.
Therapeutic Advances in Hematology (2017) Vol. 9, Iss. 1, pp. 21-46
Open Access | Times Cited: 103

Showing 1-25 of 103 citing articles:

Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
Robert Zeiser, Nikolas von Bubnoff, Jason Butler, et al.
New England Journal of Medicine (2020) Vol. 382, Iss. 19, pp. 1800-1810
Open Access | Times Cited: 663
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study
Corey Cutler, Stephanie J. Lee, Sally Arai, et al.
Blood (2021) Vol. 138, Iss. 22, pp. 2278-2289
Open Access | Times Cited: 202
Review of Graft-Versus-Host Disease
Vignesh Ramachandran, Sree S. Kolli, Lindsay C. Strowd
Dermatologic Clinics (2019) Vol. 37, Iss. 4, pp. 569-582
Closed Access | Times Cited: 121
Extracorporeal Photopheresis—An Overview
A. Cho, Christian Jantschitsch, Robert Knobler
Frontiers in Medicine (2018) Vol. 5
Open Access | Times Cited: 102
Clinical Use of Mesenchymal Stromal Cells in the Treatment of Acute Graft-versus-Host Disease
Sümeyye Elgaz, Zyrafete Kuçi, Selim Kuçi, et al.
Transfusion Medicine and Hemotherapy (2019) Vol. 46, Iss. 1, pp. 27-34
Open Access | Times Cited: 83
New Approaches for the Treatment of Chronic Graft-Versus-Host Disease: Current Status and Future Directions
Nathaniel Edward Bennett Saidu, Chiara Bonini, Anne M. Dickinson, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 83
The Role of Glucocorticoids in Inflammatory Diseases
Sybille D. Reichardt, Agathe Amouret, Chiara Muzzi, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 2921-2921
Open Access | Times Cited: 81
T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor
Hua Jiang, Denggang Fu, Alan Bidgoli, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 80
Pharmacokinetics and Pharmacodynamics of Ruxolitinib: A Review
Theo Y. Jerôme Appeldoorn, Thijs H. Oude Munnink, Linde M. Morsink, et al.
Clinical Pharmacokinetics (2023) Vol. 62, Iss. 4, pp. 559-571
Open Access | Times Cited: 29
Macrophages in graft-versus-host disease (GVHD): dual roles as therapeutic tools and targets
Atieh Raoufi, Hamed Soleimani Samarkhazan, S Nouri, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Corticosteroids impair epithelial regeneration in immune-mediated intestinal damage
Viktor Arnhold, Winston Chang, Suze A. Jansen, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 7
Open Access | Times Cited: 8
CRISPR/Cas9 deletion of MIR155HG in human T cells reduces incidence and severity of acute GVHD in a xenogeneic model
Lotus Neidemire-Colley, Shrijan Khanal, Kara M. Braunreiter, et al.
Blood Advances (2024) Vol. 8, Iss. 4, pp. 947-958
Open Access | Times Cited: 6
Extracellular Vesicle-Dependent Communication Between Mesenchymal Stromal Cells and Immune Effector Cells
Riccardo Bazzoni, Paul Takam Kamga, Ilaria Tanasi, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 49
Functional dosing of mesenchymal stromal cell-derived extracellular vesicles for the prevention of acute graft-versus-host-disease
Giada Dal Collo, Annalisa Adamo, Alessandro Gatti, et al.
Stem Cells (2020) Vol. 38, Iss. 5, pp. 698-711
Closed Access | Times Cited: 46
Prevention and Treatment of Acute Graft-versus-Host Disease in Children, Adolescents, and Young Adults
Erin Gatza, Pavan Reddy, Sung Won Choi
Biology of Blood and Marrow Transplantation (2020) Vol. 26, Iss. 5, pp. e101-e112
Open Access | Times Cited: 44
Psychosocial aspects of hematopoietic stem cell transplantation
Henrietta Janicsák, Gábor S. Ungvári, Gábor Gazdag
World Journal of Transplantation (2021) Vol. 11, Iss. 7, pp. 263-276
Open Access | Times Cited: 35
Murine CAR19 Tregs suppress acute graft-versus-host disease and maintain graft-versus-tumor responses
Sara Bolivar-Wagers, Michaël Loschi, Sujeong Jin, et al.
JCI Insight (2022) Vol. 7, Iss. 17
Open Access | Times Cited: 23
Current status of graft-versus-host disease after intestinal transplantation
Armando Ganoza, George Mazariegos, Ajai Khanna
Current Opinion in Organ Transplantation (2019) Vol. 24, Iss. 2, pp. 199-206
Closed Access | Times Cited: 38
Prevention of acute GVHD using an orthogonal IL-2/IL-2Rβ system to selectively expand regulatory T cells in vivo
Teresa Lopes Ramos, Sara Bolivar-Wagers, Sujeong Jin, et al.
Blood (2022) Vol. 141, Iss. 11, pp. 1337-1352
Open Access | Times Cited: 22
Pathophysiology of gastrointestinal acute graft‐versus‐host disease and the potential role of glucagon‐like peptide 2
Robert Zeiser, Yi‐Bin Chen, Nader N. Youssef, et al.
British Journal of Haematology (2023) Vol. 201, Iss. 4, pp. 620-627
Open Access | Times Cited: 11
Interplay between mesenchymal stromal cells and immune system: clinical applications in immune-related diseases
Panagiotis Mallis, Efstathios Michalopoulos, Theofanis Chatzistamatiou, et al.
Exploration of Immunology (2021)
Open Access | Times Cited: 24
Acute Graft-Versus-Host Disease
Ernst Holler, Hildegard Greinix, Robert Zeiser
Springer eBooks (2018), pp. 323-330
Closed Access | Times Cited: 31
Therapeutic options for steroid-refractory acute and chronic GVHD: an evolving landscape
Roman M. Shapiro, Joseph H. Antin
Expert Review of Hematology (2020) Vol. 13, Iss. 5, pp. 519-532
Closed Access | Times Cited: 27
Post-transplantation cyclophosphamide combined with tacrolimus and low-dose post-engraftment anti-thymoglobulin as GVHD prophylaxis for patients undergoing peripheral blood stem cell transplantation from haploidentical family donor: A single center analysis
Wenhui Gao, Jia-yan Zhu, Lining Wang, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 8
Extracorporeal Photopheresis (ECP) and the Potential of Novel Biomarkers in Optimizing Management of Acute and Chronic Graft vs. Host Disease (GvHD)
Matthew Mankarious, Nick C. Matthews, John A. Snowden, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top